DigitalOcean shares jump as investors look ahead to upcoming Q1 earnings after recent capital raise

DigitalOcean Holdings, Inc. (DOCN) is up 6.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most visible same-day catalyst was the company setting its next earnings date, which can prompt positioning ahead of results. The move may also reflect improving sentiment after the company recently raised equity capital to expand infrastructure capacity and pay down debt.

Details:

The company announced it plans to report first-quarter 2026 results (for the period ended March 31, 2026) before the market opens on Tuesday, May 5, 2026, followed by a conference call that morning.

In its February 24, 2026 earnings release for Q4 and full-year 2025, the company raised its revenue outlook for 2026 and discussed accelerating AI-related traction and larger-customer growth.

In late March 2026, the company priced an upsized underwritten public offering of 10,389,611 shares for gross proceeds of about $800 million, with stated uses including additional infrastructure capacity investments and paying down Term Loan A.

This could also be a technical rebound as investors reassess the near-term dilution overhang versus the potential growth impact of faster capacity expansion.

Sources:

DigitalOcean Investor Relations, U.S. Securities and Exchange Commission, Justia

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DOCN Insider Trading Activity

$DOCN insiders have traded $DOCN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

CHERIE BARRETT (SVP, Chief Accounting Officer) sold 22,000 shares for an estimated $1,204,940
MATT STEINFORT (Chief Financial Officer) sold 20,000 shares for an estimated $1,108,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DOCN Hedge Fund Activity

We have seen 196 institutional investors add shares of $DOCN stock to their portfolio, and 151 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG added 1,573,245 shares (+338.4%) to their portfolio in Q4 2025, for an estimated $75,704,549
BALYASNY ASSET MANAGEMENT L.P. removed 838,724 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $40,359,398
NORGES BANK removed 792,480 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $38,134,137
LAZARD ASSET MANAGEMENT LLC removed 776,966 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $37,387,603
MARSHALL WACE, LLP removed 705,917 shares (-96.4%) from their portfolio in Q4 2025, for an estimated $33,968,726
ALYESKA INVESTMENT GROUP, L.P. removed 638,401 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $30,719,856
LMR PARTNERS LLP added 620,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $29,834,400

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DOCN Analyst Ratings

Wall Street analysts have issued reports on $DOCN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

B of A Securities issued a "Buy" rating on 11/06/2025
Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $DOCN, check out Quiver Quantitative's $DOCN forecast page.

$DOCN Price Targets

Multiple analysts have issued price targets for $DOCN recently. We have seen 10 analysts offer price targets for $DOCN in the last 6 months, with a median target of $97.5.

Here are some recent targets:

Raimo Lenschow from Barclays set a target price of $105.0 on 04/21/2026
Radi Sultan from UBS set a target price of $97.0 on 04/21/2026
Wamsi Mohan from B of A Securities set a target price of $107.0 on 04/09/2026
James Fish from Piper Sandler set a target price of $98.0 on 04/07/2026
Patrick Walravens from Citizens set a target price of $105.0 on 03/26/2026
Timothy Horan from Oppenheimer set a target price of $100.0 on 03/18/2026
Gabriela Borges from Goldman Sachs set a target price of $78.0 on 02/25/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.